Ryeqo Norge - norsk - Statens legemiddelverk

ryeqo

2care4 aps - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg

Ryeqo Norge - norsk - Statens legemiddelverk

ryeqo

orifarm as - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg

Ryeqo Den europeiske union - norsk - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyomer - hypofysiske og hypotalamiske hormoner og analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.